HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

CA IV may be target antigen in autoimmune pancreatitis

Japanese researchers have uncovered a serum antibody that may prove to be a marker for disease affecting multiple exocrine glands—like autoimmune pancreatitis (AIP) and Sjögren’s syndrome (SS). The target antigen—carbonic anhydrase isozyme IV (CA IV)—is commonly found in exocrine gland epithelia.

The antibody was significantly more common among patients with definite (27%) or probable (43%) AIP and SS (45%) than among those with pancreatic cancer (14%) or alcoholic chronic pancreatitis (13%), when compared with healthy controls in an ELISA screen with truncated recombinant CA IV antigen. The same trend occurred in a parallel screen with a synthetic peptide of CA IV. Reactivity of in vivo CA IV—the entire protein in its native configuration—remains to be confirmed, as does its potential role in pathogenesis.

Fifteen patients had definite AIP and 14 probable AIP; 15 had alcoholic chronic pancreatitis and 14 pancreatic cancer; 20 patients had SS; and there were 30 controls.

. . . [Full text of this article]